Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Direct ✕Bank of India Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseHDFCBank of India
NAV₹23.6750₹10.1100
NAV date20 Nov 202620 Nov 2026
History3.1 years2.2 years
Expense ratio1.1%1.4%
Stars★★★★★Not rated
Growth Score94.50—

Returns

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
1 month+12.97%+5.42%
3 months+7.13%+1.00%
6 months+17.84%+9.30%
YTD+33.73%+10.73%
1 year+32.20%+7.10%
3 years (CAGR)+30.70%—
5 years (CAGR)——
10 years (CAGR)——
Since launch+31.83%+0.40%

Risk

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
Volatility15.8%—
Downside volatility8.5%—
Sharpe1.53—
Sortino2.86—
Calmar2.06—
Return / risk1.95—
Deepest fall−14.91%−25.21%
Days to recover126—
Below its high+0.00%−3.44%

Against benchmark

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
Alpha+7.54%—
Beta0.97—
R²85.0%—
Up capture108.9%—
Down capture71.0%—
Tracking error6.1%—
Information ratio1.17—
Treynor0.24—

Consistency

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
Best 1-year+67.01%+12.64%
Middle 1-year+23.25%+1.89%
Worst 1-year+1.71%−13.31%
1-year periods with a loss0.0%41.7%
Middle 3-year+30.22%—
Positive months72.2%—
Best day+3.18%+4.23%
Worst day−3.61%−3.87%
Worst 5% day−1.51%−1.77%
Positive days58.3%49.7%
NAVs a year247247

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundBank of India Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR+27.71%—
1-year XIRR+41.37%+15.54%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth